The mental health and lifestyle impacts of COVID-19 on bipolar disorder

Karantonis, James A; Rossell, Susan L.; Berk, Michael; Rheenen, Tamsyn E Van

doi:10.1016/j.jad.2020.12.186

Cited by 42 publications

(53 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Of these, 440 studies were excluded at the title/abstract level, and an additional 198 records were excluded following full-text review, as detailed in the supplementary material n.2. A total of 14 studies ( Ackerman et al, 2020 , 2021 ; Carmassi et al, 2020 ; Carta et al, 2021 ; Dattoli et al, 2020 ; Karantonis et al, 2021 ; Korten et al, 2021 ; Lazzari et al, 2020 ; McBride et al, 2021 ; Tundo et al, 2021 ; Uvais, 2020 ; Wang et al, 2021 ; Yin et al, 2020 ; Yocum et al, 2021 ) were eligible for inclusion. Please refer to figure 1 (study flow) and table 1 for additional details.…”

Section: Resultsmentioning

confidence: 99%

“…Please refer to figure 1 (study flow) and table 1 for additional details. Among the included studies, 6 studies ( Ackerman et al, 2020 ; Carmassi et al, 2020 ; Dattoli et al, 2020 ; Lazzari et al, 2020 ; Uvais, 2020 ; Yin et al, 2020 ) were published in 2020, and 8 studies ( Ackerman et al, 2021 ; Carta et al, 2021 ; Karantonis et al, 2021 ; Korten et al, 2021 ; McBride et al, 2021 ; Tundo et al, 2021 ; Wang et al, 2021 ; Yocum et al, 2021 ) were published in the year 2021. A total of 6 studies ( Carmassi et al, 2020 ; Dattoli et al, 2020 ; Korten et al, 2021 ; Lazzari et al, 2020 ; McBride et al, 2021 ; Tundo et al, 2021 ) were conducted in Europe, 4 studies ( Ackerman et al, 2020 , 2021 ; Wang et al, 2021 ; Yocum et al, 2021 ) in North America, 2 studies ( Uvais, 2020 ; Yin et al, 2020 ) in Asia, one study ( Karantonis et al, 2021 ) in Oceania, and one study included two different samples from independent geographical regions (Europe and Africa) ( Carta et al, 2021 ).…”

Section: Resultsmentioning

confidence: 99%

“…Among the included studies, 6 studies ( Ackerman et al, 2020 ; Carmassi et al, 2020 ; Dattoli et al, 2020 ; Lazzari et al, 2020 ; Uvais, 2020 ; Yin et al, 2020 ) were published in 2020, and 8 studies ( Ackerman et al, 2021 ; Carta et al, 2021 ; Karantonis et al, 2021 ; Korten et al, 2021 ; McBride et al, 2021 ; Tundo et al, 2021 ; Wang et al, 2021 ; Yocum et al, 2021 ) were published in the year 2021. A total of 6 studies ( Carmassi et al, 2020 ; Dattoli et al, 2020 ; Korten et al, 2021 ; Lazzari et al, 2020 ; McBride et al, 2021 ; Tundo et al, 2021 ) were conducted in Europe, 4 studies ( Ackerman et al, 2020 , 2021 ; Wang et al, 2021 ; Yocum et al, 2021 ) in North America, 2 studies ( Uvais, 2020 ; Yin et al, 2020 ) in Asia, one study ( Karantonis et al, 2021 ) in Oceania, and one study included two different samples from independent geographical regions (Europe and Africa) ( Carta et al, 2021 ). Concerning study designs, 6 studies ( Ackerman et al, 2021 ; Carmassi et al, 2020 ; Dattoli et al, 2020 ; Karantonis et al, 2021 ; McBride et al, 2021 ; Tundo et al, 2021 ) were cross-sectional, 3 studies ( Carta et al, 2021 ; Korten et al, 2021 ; Yocum et al, 2021 ) were prospective cohort studies, one study( Ackerman et al, 2020 ) was a retrospective cohort study, and one study( Wang et al, 2021 ) was a case-control study, and 3 studies ( Lazzari et al, 2020 ; Uvais, 2020 ; Yin et al, 2020 ) were case reports/series.…”

Section: Resultsmentioning

confidence: 99%

“…A total of 6 studies ( Carmassi et al, 2020 ; Dattoli et al, 2020 ; Korten et al, 2021 ; Lazzari et al, 2020 ; McBride et al, 2021 ; Tundo et al, 2021 ) were conducted in Europe, 4 studies ( Ackerman et al, 2020 , 2021 ; Wang et al, 2021 ; Yocum et al, 2021 ) in North America, 2 studies ( Uvais, 2020 ; Yin et al, 2020 ) in Asia, one study ( Karantonis et al, 2021 ) in Oceania, and one study included two different samples from independent geographical regions (Europe and Africa) ( Carta et al, 2021 ). Concerning study designs, 6 studies ( Ackerman et al, 2021 ; Carmassi et al, 2020 ; Dattoli et al, 2020 ; Karantonis et al, 2021 ; McBride et al, 2021 ; Tundo et al, 2021 ) were cross-sectional, 3 studies ( Carta et al, 2021 ; Korten et al, 2021 ; Yocum et al, 2021 ) were prospective cohort studies, one study( Ackerman et al, 2020 ) was a retrospective cohort study, and one study( Wang et al, 2021 ) was a case-control study, and 3 studies ( Lazzari et al, 2020 ; Uvais, 2020 ; Yin et al, 2020 ) were case reports/series. The diagnosis of BD was validated according to the DSM-5 by 8 studies( Ackerman et al, 2020 , 2021 ; Carmassi et al, 2020 ; Carta et al, 2021 ; Dattoli et al, 2020 ; Tundo et al, 2021 ; Uvais, 2020 ; Yin et al, 2020 ), the DSM-IV or DSM-IV-TR in 3 studies ( Karantonis et al, 2021 ; Korten et al, 2021 ; Yocum et al, 2021 ), and the ICD-10 in 3 studies ( Lazzari et al, 2020 ; McBride et al, 2021 ; Wang et al, 2021 ); additionally, the Mini-International Neuropsychiatric Interview (MINI) was adopted in 4 studies ( Ackerman et al, 2020 , 2021 ; Karantonis et al, 2021 ; Korten et al, 2021 ), and the Structured Clinical Interview for DSM-5 (SCID-5) was used in one st...…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Implications of the COVID-19 pandemic for people with bipolar disorders: A scoping review

Fornaro

Prisco

Billeci

et al. 2021

Journal of Affective Disorders

Self Cite

View full text Add to dashboard Cite

Introduction The COVID-19 (coronavirus disease 2019)-related pandemic represents a global source of societal and health burden. Yet, the impact of the pandemic on people with severe mental illness, including bipolar disorder (BD), remains unclear, warranting scoping review on the matter. Methods The MEDLINE and EMBASE databases were systematically searched from inception up to April 24, 2021, adopting broad inclusion criteria to assess a variety of clinical and public health themes related to people with a primary diagnosis of BD during the COVID-19 pandemics. The present work complying with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR) registered in the Open Science Framework (OSF) repository ( https://osf.io/7evpx/ ). Results Fourteen papers informed the present scoping review. Four major themes were identified: i) impact of COVID-19-related stressors on BD; ii) impact of COVID-19 on mental health service utilization among people with BD; iii) impact of BD on the risk of acquiring SARS-CoV-2 infection; iv) engagement in preventative behaviors among people with BD. Additional themes warranting further research were nonetheless detected. Limitations Further original studies are needed. Conclusion The present study confirmed the high-vulnerability hypothesis concerning people with BD versus the general population, reinforcing the need for further research related to the COVID-19 pandemic. Additional information is warranted to compare the impact of the pandemic period among BD people against pre-pandemic records, the general population, and other severe mental illnesses, namely people with schizophrenia or major depressive disorder, to inform the public health and the delivery of patient-tailored interventions.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Implications of the COVID-19 pandemic for people with bipolar disorders: A scoping review

Fornaro

Prisco

Billeci

et al. 2021

Journal of Affective Disorders

Self Cite

View full text Add to dashboard Cite

show abstract

“…However, these factors are not specific for anxiety and depressive disorders and are expected to decrease visit rates for all diagnoses. Studies have reported no significant change regarding the visit rates bipolar disorder patients during the pandemic [ 35 , 36 ]. Possible explanations of these contradictory findings on anxiety, depression, and bipolar disorders are the relatively small sample size and different methodology of these studies, as well as cultural differences of the countries that affect psychological reactions of the populations.…”

Section: Discussionmentioning

confidence: 99%

Psychiatric emergency visit trends and characteristics in a mental health epicenter in Istanbul during COVID-19 lockdown

Yalçın

Baş

Bilici

et al. 2021

Soc Psychiatry Psychiatr Epidemiol

View full text Add to dashboard Cite

Background We aimed to explore the impact of the preventive measures and partial lockdown to the psychiatric emergency department (PED) visits during COVID-19 pandemic in a mental health epicenter in Istanbul. Methods A total of 5839 patients admitted to PED during the lockdown period (LP) between March 30 and May 31, 2020, were enrolled in this retrospective cohort study. Data of these patients were compared to those of patients in the same period in 2019 between April 1 and June 2, 2019 (non-LP). We also investigated the monthly number of PED visits and hospitalizations between March 1 and December 31, 2020, and compared it to the same period in 2019. Results The volume of PED visits and hospitalizations in LP decreased by 12% and 41.6%, respectively. The rates of patients presenting anxiety and depressive disorders and bipolar disorders were found to significantly increase in LP than non-LP ( p < 0.001; p < 0.001; p < 0.01, respectively). Depressive disorders, prior history of mental illness, and aggressive behavior were found to predict frequent PED visits while decrease in age and male gender found to predict hospitalizations. Regarding suicide attempt, younger patients and those with new-onset mental disorders were found to be at high risk in LP. Patients diagnosed with COVID-19 in PED visits were mostly with psychotic and bipolar disorders. Conclusion Policy-makers should focus on studies on mental health services to reorganize and enhance such services, which are crucial to prevent and manage adverse mental health consequences of the pandemic and congestion in PEDs.

show abstract

Effects of the COVID‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms

et al. 2021

View full text Add to dashboard Cite

Background:The coronavirus disease 2019 (COVID-19) pandemic interfered in the daily lives of people and is assumed to adversely affect mental health. However, the effects on mood (in)stability of bipolar disorder (BD) patients and the comparison to pre-COVID-19 symptom severity levels are unknown.Method: Between April and September, 2020, symptoms and well-being were assessed in the Bipolar Netherlands Cohort (BINCO) study of recently diagnosed patients with BD I and II. The questionnaire contained questions regarding manic and depressive symptoms (YMRS and ASRM, QIDS), worry (PSWQ), stress (PSS), loneliness, sleep, fear for COVID-19, positive coping, and substance use. As manic, depressive and stress symptoms levels were assessed pre-COVID-19, their trajectories during the lockdown restrictions were estimated using mixed models.Results: Of the 70 invited BD patients, 36 (51%) responded at least once (mean age of 36.7 years, 54% female, and 31% BD type 1) to the COVID-19 assessments. There was a significant increase (X 2 = 17.06; p = .004) in (hypo)manic symptoms from baseline during the first COVID-19 wave, with a decrease thereafter. Fear of COVID-19 (X 2 = 18.01; p = .003) and positive coping (X 2 = 12.44; p = .03) were the highest at the start of the pandemic and decreased thereafter. Other scales including depression and stress symptoms did not vary significantly over time. Conclusion:We found a meaningful increase in manic symptomatology from pre-COVID-19 into the initial phases of the pandemic in BD patients. These symptoms decreased along with fear of COVID-19 and positive coping during the following months when lockdown measures were eased.

show abstract

The mental health and lifestyle impacts of COVID-19 on bipolar disorder

Cited by 42 publications

References 14 publications

Implications of the COVID-19 pandemic for people with bipolar disorders: A scoping review

Implications of the COVID-19 pandemic for people with bipolar disorders: A scoping review

Psychiatric emergency visit trends and characteristics in a mental health epicenter in Istanbul during COVID-19 lockdown

Effects of the COVID‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms

Contact Info

Product

Resources

About